Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gleason

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
The Journal of Reproductive Medicine|May 27, 2005
Roles of medical consultants and expert witnesses in cerebral palsy litigation: a reviewAdam Ostrzenski, Bartosz A Ostrzenski, James P Gleason, et al.
Gynecologic Oncology|December 1, 1991
Coexisting intraductal breast carcinoma and metastatic choriocarcinoma presenting as a breast massR D Alvarez, B P Gleason, H Gore, et al.
Cancer Research|September 1, 1984
Isolation and characterization of an estrogen-inhibited variant derived from the MCF-7 breast cancer cell lineD A Bronzert, T J Triche, P Gleason, et al.
Journal of Managed Care & Specialty Pharmacy|November 25, 2016
Association of a Controlled Substance Scoring Algorithm with Health Care Costs and Hospitalizations: A Cohort StudyCatherine I Starner, Yang Qiu, Pinar Karaca-Mandic, et al.
Urology|March 1, 1993
Acute lobar nephronia of renal transplant allograftJ V Thomalla, P Gleason, S B Leapman, et al.
Journal of Managed Care & Specialty Pharmacy|July 31, 2023
Descriptive, real-world treatment patterns, resource use, and total cost of care among eculizumab- and ravulizumab-treated members with paroxysmal nocturnal hemoglobinuriaKelly C Broderick, James P Burke, Jesse Fishman, et al.
The Annals of Pharmacotherapy|March 13, 1998
Intermittent-dose metronidazole-induced peripheral neuropathyL M Dreger, P P Gleason, T K Chowdhry, et al.
Journal of Managed Care Pharmacy : JMCP|April 4, 2012
Rosiglitazone prior authorization safety policy: a cohort studyCatherine I Starner, Beckie Fenrick, John Coleman, et al.
Pharmacotherapy|July 12, 2005
Medical and pharmacy expenditures after implementation of a cyclooxygenase-2 inhibitor prior authorization programPatrick P Gleason, Clint Williams, Sally Hrdy, et al.
The American Journal of Geriatric Pharmacotherapy|March 14, 2009
Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderlyCatherine I Starner, Sheila A Norman, Richard G Reynolds, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Reproductive Medicine|May 27, 2005
Roles of medical consultants and expert witnesses in cerebral palsy litigation: a reviewAdam Ostrzenski, Bartosz A Ostrzenski, James P Gleason, et al.
Gynecologic Oncology|December 1, 1991
Coexisting intraductal breast carcinoma and metastatic choriocarcinoma presenting as a breast massR D Alvarez, B P Gleason, H Gore, et al.
Cancer Research|September 1, 1984
Isolation and characterization of an estrogen-inhibited variant derived from the MCF-7 breast cancer cell lineD A Bronzert, T J Triche, P Gleason, et al.
Journal of Managed Care & Specialty Pharmacy|November 25, 2016
Association of a Controlled Substance Scoring Algorithm with Health Care Costs and Hospitalizations: A Cohort StudyCatherine I Starner, Yang Qiu, Pinar Karaca-Mandic, et al.
Urology|March 1, 1993
Acute lobar nephronia of renal transplant allograftJ V Thomalla, P Gleason, S B Leapman, et al.
Journal of Managed Care & Specialty Pharmacy|July 31, 2023
Descriptive, real-world treatment patterns, resource use, and total cost of care among eculizumab- and ravulizumab-treated members with paroxysmal nocturnal hemoglobinuriaKelly C Broderick, James P Burke, Jesse Fishman, et al.
The Annals of Pharmacotherapy|March 13, 1998
Intermittent-dose metronidazole-induced peripheral neuropathyL M Dreger, P P Gleason, T K Chowdhry, et al.
Journal of Managed Care Pharmacy : JMCP|April 4, 2012
Rosiglitazone prior authorization safety policy: a cohort studyCatherine I Starner, Beckie Fenrick, John Coleman, et al.
Pharmacotherapy|July 12, 2005
Medical and pharmacy expenditures after implementation of a cyclooxygenase-2 inhibitor prior authorization programPatrick P Gleason, Clint Williams, Sally Hrdy, et al.
The American Journal of Geriatric Pharmacotherapy|March 14, 2009
Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderlyCatherine I Starner, Sheila A Norman, Richard G Reynolds, et al.
Pageof 9